ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa

ClinicalTrials.gov ID: NCT00782340

Public ClinicalTrials.gov record NCT00782340. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 7:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III, Multi-Center, Study to Assess the Clinical Effect of Droxidopa in Subjects With Primary Autonomic Failure, Dopamine Beta Hydroxylase Deficiency or Non-Diabetic Neuropathy and Symptomatic NOH

Study identification

NCT ID
NCT00782340
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Chelsea Therapeutics
Industry
Enrollment
263 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2008
Primary completion
Aug 31, 2010
Completion
Aug 31, 2010
Last update posted
May 15, 2014

2008 – 2010

United States locations

U.S. sites
14
U.S. states
12
U.S. cities
14
Facility City State ZIP Site status
North Alabama Neuroscience Huntsville Alabama 35801
Mayo Clinic-Arizona Scottsdale Arizona 85340
Arkansas Cardiology Little Rock Arkansas 72205
University of California, Irvine Irvine California 92697
Bradenton Neurology, Inc Bradenton Florida 34205
Suncoast Neuroscience Associates, Inc St. Petersburg Florida 33701
University of Kansas Medical Center Kansas City Kansas 66160
Cncs, Ninds,Nih Bethesda Maryland 20892
Nerological Reserch Center at Hattiesburg Hattiesburg Mississippi 39401
North Shore Hospital Manshasette New York 11030
Pennsylvania Hospital of the University of PA Health System- Department of Neurology Philadelphia Pennsylvania 19107
HAN Neurological Associates Upland Pennsylvania 19013
Baylor College of Medicine Houston Texas 77030
Evergreen Hospital Medical Center; Booth Gardner Parkinson's Care Center Kirkland Washington 98034

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00782340, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 15, 2014 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00782340 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →